Medical Developments International has released a press release.
MVP Announces FY22 Full Year Results
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
In the deck
Earlier from Medical Developments International
- FY22 Full Year Accounts
- Security Class Suspension from Quotation MVPO
- Prospectus - Entitlement Offer and Options
- Investor Presentation - $30m Capital Raise and FY22 Guidance
- MVP Announces $30m Capital Raise and FY22 Guidance
Later from Medical Developments International
- FY222 Full Year Results Investor Presentation
- Completion of Retail Entitlement Offer
- Security Class Reinstatement to Quotation MVPO
- Chair and CEO Presentation to Shareholders
- China Clinical Trials Discontinued
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International